Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alkaline Phosphatase to prevent ischemia reperfusion injury in living kidney transplantation
2017-004737-85Phase 2Terminated
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2020
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of bovine intestinal alkaline phosphatase in ischemia-reperfusion injury (IRI), sponsored by Amsterdam University Medical Center. Primary endpoint: Graft function at one year after kidney transplantation (iohexol clearance). Started Nov 2020; status: terminated.
02
Drugs
bovine intestinal alkaline phosphatase
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on 2017-004737-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004737-85.